Corcept Therapeutics Incorporated (BIT:1CORT)

Corcept Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	2,989	3,688	5,297	3,359	2,190	2,098
Market Cap Growth	-50.74%	-30.38%	57.70%	53.35%	4.41%	-31.31%
Enterprise Value	2,529	3,320	4,919	2,990	1,758	1,874
PE Ratio	35.75	42.44	40.97	34.55	23.34	22.25
Forward PE	84.90	55.53	32.11	32.61	19.95	21.01
PEG Ratio	-	-	-	-	-	1.50
PS Ratio	4.61	4.84	7.85	6.96	5.45	5.73
PB Ratio	5.42	5.69	7.79	6.63	4.36	5.58
P/TBV Ratio	5.32	6.45	8.41	7.16	4.69	6.64
P/FCF Ratio	24.75	26.01	27.01	26.54	18.26	12.53
P/OCF Ratio	24.72	25.97	26.71	26.51	18.20	12.49
EV/Sales Ratio	3.80	4.36	7.29	6.20	4.38	5.12
EV/EBITDA Ratio	59.73	72.27	35.71	27.61	15.44	14.88
EV/EBIT Ratio	64.59	74.12	35.92	27.87	15.61	15.06
EV/FCF Ratio	20.95	23.42	25.08	23.63	14.66	11.19
Debt / Equity Ratio	0.01	0.01	0.01	0	0	0
Debt / EBITDA Ratio	0.13	0.13	0.05	0.00	0.01	0.00
Debt / FCF Ratio	0.04	0.04	0.04	0.00	0.01	0.00
Net Debt / Equity Ratio	-0.56	-0.56	-0.55	-0.73	-0.86	-0.59
Net Debt / EBITDA Ratio	-7.97	-7.97	-2.73	-3.40	-3.78	-1.77
Net Debt / FCF Ratio	-2.58	-2.58	-1.92	-2.91	-3.59	-1.33
Asset Turnover	0.91	0.91	0.92	0.80	0.80	0.74
Inventory Turnover	1.03	1.03	1.08	0.94	0.97	1.07
Quick Ratio	2.60	2.60	3.11	4.05	6.58	5.28
Current Ratio	2.92	2.92	3.35	4.39	6.89	5.60
Return on Equity (ROE)	15.01%	15.01%	23.81%	21.05%	23.11%	25.03%
Return on Assets (ROA)	8.01%	8.01%	16.38%	15.17%	19.52%	22.51%
Return on Invested Capital (ROIC)	21.78%	21.78%	51.37%	79.72%	84.17%	93.83%
Return on Capital Employed (ROCE)	6.54%	6.54%	22.51%	20.87%	25.39%	27.65%
Earnings Yield	2.80%	2.36%	2.44%	2.89%	4.28%	4.49%
FCF Yield	4.04%	3.84%	3.70%	3.77%	5.48%	7.98%
Buyback Yield / Dilution	5.98%	5.98%	0.54%	4.43%	0.79%	14.43%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.